RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Gross profit

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndGross profit (Million USD)YoY (%)
Dec 31, 20248,064+5.48%
Dec 31, 20237,645+9.64%
Dec 31, 20226,973-8.18%
Dec 31, 20217,594-1.71%
Dec 31, 20207,726+2.51%
Dec 31, 20197,537-9.15%
Dec 31, 20188,296-23.36%
Dec 31, 201710,825-8.72%
Dec 31, 201611,859+4.43%
Dec 31, 201511,356+2.71%
Dec 31, 201411,056+3.26%
Dec 31, 201310,707+0.52%
Dec 31, 201210,652+11.95%
Dec 31, 20119,515+4.96%
Dec 31, 20109,065

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)